Jessica Hassel

54PUBLICATIONS
228CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Oct 30, 2026
Patient-reported patterns in follow-up care of metastatic uveal melanoma: A survey in specialized dermato-oncological centers.

|Aug 11, 2026
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|Apr 27, 2026
Re-Exposure of a PD-1 Inhibitor After Previous Immune-Related Adverse Events.

|Apr 21, 2026
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition.

|Mar 14, 2026
Mycophenolate Mofetil for Treatment of Ipilimumab-Induced Colitis in Patients with Metastatic Melanoma.

Christina Naoum, Julia K Winkler, Pawel Majenka

Pageof 9

Frequent Collaborators

12 joint publications

Ralf Gutzmer

8 joint publications

Christoffer Gebhardt

8 joint publications

Dirk Schadendorf

6 joint publications

Selma Ugurel